首页 | 本学科首页   官方微博 | 高级检索  
     

VEGF-C和Flt-4在舌鳞癌组织中的表达及其临床意义
引用本文:Li QL,Chen FJ,Zeng ZY,Yang AK,Wu QL,Zhang HZ,Hou JH. VEGF-C和Flt-4在舌鳞癌组织中的表达及其临床意义[J]. 癌症, 2006, 25(2): 235-240
作者姓名:Li QL  Chen FJ  Zeng ZY  Yang AK  Wu QL  Zhang HZ  Hou JH
作者单位:华南肿瘤学国家重点实验室,广东,广州,510060;中山大学肿瘤防治中心头颈科,广东,广州,510060;华南肿瘤学国家重点实验室,广东,广州,510060;中山大学肿瘤防治中心头颈科,广东,广州,510060;华南肿瘤学国家重点实验室,广东,广州,510060;中山大学肿瘤防治中心头颈科,广东,广州,510060;华南肿瘤学国家重点实验室,广东,广州,510060;中山大学肿瘤防治中心头颈科,广东,广州,510060
摘    要:背景与目的:近年来研究发现,血管内皮细胞生长因子-C(vascular endothelial growth factor—C,VEGF—C)可诱导实体瘤内或瘤周的淋巴管生成.与肿瘤的淋巴道转移密切相关。本研究旨在检测VEGF—C及其受体Flt-4(fms—like tyrosine kinase-4)在舌鳞癌中的表达,并探讨其临床意义。方法:收集1988年1月至1996年12月在中山大学肿瘤防治中心治疗的舌鳞癌99例及同期收治的舌良性上皮病变17例,免疫组化LSAB方法检测舌癌组织中VEGF-C和Flt-4的表达,分析VEGF—C和Flt-4表达与舌鳞癌临床病理特征及预后的关系。结果:VEGF—C和Flt-4在舌鳞癌中的阳性率(35.35%vs.5.88%)均显著高于舌良性上皮性病变(40.40%vs.5.88%,P〈0.05)。淋巴结转移组的VEGF—C阳性率显著高于无淋巴结转移组(43.75%vs.20.00%,P〈0.05),Ⅰ+Ⅱ期组的VEGF—C阳性率显著低于Ⅲ+Ⅳ期组(18.52%vs.41.67%,P〈0.05)。VEGF—C阳性组和Flt-4阳性组的5年生存率均显著低于阴性组(45.08%vs.68.25%,38.03%vs.75.46%,P〈0.05)。结论:VEGF—C和Flt-4在舌鳞癌的叶性率显著高于舌良性上皮性病变。VEGF—C表达与颈淋巴结转移、临床分期显著相关。VEGF—C和Flt-4表达与舌鳞癌的预后有关.

关 键 词:舌肿瘤    鳞状细胞  血管内皮细胞生长因子-C  血管内皮细胞生长因子受体-3  临床病理特征  预后
文章编号:1000-467X(2006)02-0235-06
收稿时间:2005-04-20
修稿时间:2005-04-202005-08-10

Expression and clinical significance of VEGF-C and Flt-4 in tongue squamous cell carcinoma
Li Qiu-Li,Chen Fu-Jin,Zeng Zong-Yuan,Yang An-Kui,Wu Qiu-Liang,Zhang Hui-Zhong,Hou Jing-Hui. Expression and clinical significance of VEGF-C and Flt-4 in tongue squamous cell carcinoma[J]. Chinese journal of cancer, 2006, 25(2): 235-240
Authors:Li Qiu-Li  Chen Fu-Jin  Zeng Zong-Yuan  Yang An-Kui  Wu Qiu-Liang  Zhang Hui-Zhong  Hou Jing-Hui
Affiliation:1.State Key Laboratory of Oncology in South China, Guangzhou , Guangdong , 510060, P, R. China; 2. Department of Head and Neck Surgery , Cancer Center, Sun Yat-sen University, Guangzhou , Guangdong , 510060, P, R. China ;3. Department of Pathology, Cancer Center, Sun Yat-sen University, Guangzhou , Guangdong , 510060, P. R. China
Abstract:BACKGROUND & OBJECTIVE: Vascular endothelial growth factor-C (VEGF-C) could induce lymphangiogenesis in or around solid tumor, and is closely related with lymphatic metastasis. This study was to investigate the expression and clinical significance of VEGF-C and its receptor fms-like tyrosine kinase-4 (Flt-4) in tongue squamous cell carcinoma (TSCC). METHODS: The expression of VEGF-C and Flt-4 in 99 specimens of TSCC and 17 specimens of benign tongue epithelial lesions was detected by LSAB immunohistochemistry. The correlations of expression of VEGF-C and Flt-4 to the clinicopathologic features and prognosis of TSCC were analyzed. RESULTS: The positive rates of VEGF-C and Flt-4 were significantly higher in TSCC than in benign tongue epithelial lesion (35.35% vs. 5.88%, and 40.40% vs. 5.88%, P<0.05). The positive rate of VEGF-C was significantly higher in TSCC with cervical lymph node metastasis than in TSCC without metastasis (43.75% vs. 20%, P<0.05), and significantly lower in stage I-II TSCC than in stage III-IV TSCC (18.52% vs. 41.67%, P<0.05). The cumulative 5-year survival rates of the patients with positive expression of either VEGF-C or Flt-4 were significantly lower than those of the patients with negative expression of either VEGF-C or Flt-4 (45.08% vs. 68.25%, and 38.03% vs. 75.46%, P<0.05). CONCLUSIONS: The positive rates of VEGF-C and Flt-4 are significantly higher in TSCC than in benign tongue epithelial lesions. The expression of VEGF-C is correlated with cervical lymph node metastasis and clinical stage. The prognosis of TSCC patients with high expression of VEGF-C and Flt-4 is poor.
Keywords:Tongue neoplasms   Carcinoma, squamous cell   Vascular endothelial growth factor-C   Vascular endothelial growth factor receptor-3  Clinicopathologic features   Prognosis
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号